{"id":"W3026759727","doi":"10.1016/j.annonc.2020.03.175","title":"41P A window-of-opportunity study with atezolizumab and the oncolityc virus pelareorep in early breast cancer (REO-027, AWARE-1)","year":2020,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":false,"ca_institutions":"Oncolytics Biotech (Canada)","funders":"","keywords":"Atezolizumab; Medicine; Window of opportunity; Breast cancer; Oncology; Internal medicine; Cancer; Gynecology; Immunotherapy; Pembrolizumab","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009167019,0.0004597566,0.000745573,0.0002693009,0.0004353234,0.0008296272,0.0006713908,0.001356807,0.005625924],"category_scores_gemma":[0.0006398231,0.0003713318,0.0009821862,0.0002190267,0.0005885549,0.0006554233,0.0002126196,0.002734273,0.000717885],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006874278,"about_ca_system_score_gemma":0.0008249041,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002554217,"about_ca_topic_score_gemma":0.001716138,"domain_scores_codex":[0.9994809,0.0001616581,0.00001422708,0.00007355357,0.00004303372,0.0002266871],"domain_scores_gemma":[0.9996723,0.0001248531,0.00002158671,0.00004417788,0.00001789205,0.0001192101],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.2472793,0.0618429,0.005981391,0.0002982125,0.0006212165,0.002895148,0.0004941509,0.001651067,0.5924965,0.003042731,0.005634655,0.07776285],"study_design_scores_gemma":[0.04247325,0.7037715,0.02716133,0.00006130675,0.0008104748,0.00309594,0.0005812724,0.00464735,0.1907826,0.001717852,0.02478638,0.0001108517],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9943784,0.001151096,0.0004863522,0.0005570548,0.000270737,0.0002050893,0.0005088316,0.00003012079,0.002412349],"genre_scores_gemma":[0.991993,0.0009874137,0.0005787915,0.0004273029,0.0002184434,0.0002166713,0.0006876843,0.00002734333,0.004863378],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005625924,"threshold_uncertainty_score":0.01882064,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07105510699963798,"score_gpt":0.3791602937760939,"score_spread":0.3081051867764559,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}